Frye J L, Thompson D F
College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City 73117.
J Clin Pharm Ther. 1993 Feb;18(1):45-8. doi: 10.1111/j.1365-2710.1993.tb00565.x.
Thrombocytosis is generally defined as platelet counts greater than 400,000/mm3. Thrombocytosis can be either primary or secondary. Adrenalin was one of the first drugs noticed to cause platelet elevations, probably due to demargination of platelets in the pulmonary vasculature. Vinca alkaloids have the most convincing data to show that they can induce thrombocytosis through their thrombocyte-stimulating properties. Miconazole has been implicated in causing thrombocytosis and has a documented case validated by drug rechallenge. Iron, predictably, can cause a transient thrombocytosis. The beta-lactam antibiotic data are very difficult to interpret due to the possibility of an acute-phase reaction in an infected patient being the cause of the thrombocytosis.
血小板增多症通常定义为血小板计数大于400,000/mm³。血小板增多症可分为原发性或继发性。肾上腺素是最早被发现可导致血小板升高的药物之一,这可能是由于肺血管系统中血小板的边缘池解离所致。长春花生物碱有最具说服力的数据表明它们可通过其刺激血小板的特性诱导血小板增多症。咪康唑与血小板增多症的发生有关,并有药物激发试验证实的病例记录。可以预见,铁会导致短暂性血小板增多症。由于感染患者的急性期反应可能是血小板增多症的原因,β-内酰胺类抗生素的数据很难解释。